ACHE and Alzheimer disease: Current therapies for Alzheimer disease (AD), such as the acetylcholinesterase inhibitors and the NMDA receptor inhibitors, may provide moderate symptomatic delay at various stages of the disease, but do not arrest the disease progression or induce meaningful remission.